Key result
Statins are linked to higher HbA1c and fasting glucose, but cardiovascular benefits outweigh risks.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
The Food and Drug Administration has added information to statin labels regarding an effect on diabetes, noting reported increases in glycated hemoglobin and fasting serum glucose levels but adding that it believes that the cardiovascular benefits outweigh the risks.
No takes yet. Share an insight, caveat, or question.
Allison B. Goldfine (2012) studied this question. Statins are associated with increased glycated hemoglobin and fasting glucose levels, but the FDA maintains that their cardiovascular benefits outweigh these risks.
Synapse has enriched 10 related papers. Consider them for comparative context: